![Francis Lidgey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francis Lidgey
Directeur/Membre du Conseil chez Phibex Plc
Profil
Francis John Lidgey is currently a Director at Phibex Plc and a Professor-Emeritus at Oxford Brookes University since 1992.
He previously held positions as Non-Executive Chairman at Levrett Plc, Non-Executive Director at Nuformix Technologies Ltd., Independent Non-Executive Director at Nuformix Plc, and Director at LTP Electronics Ltd.
Lidgey earned doctorate degrees from The University of Newcastle in 1977 and the University of Surrey in 1973.
Postes actifs de Francis Lidgey
Sociétés | Poste | Début |
---|---|---|
Oxford Brookes University | Corporate Officer/Principal | 01/01/1992 |
Phibex Plc | Directeur/Membre du Conseil | - |
Anciens postes connus de Francis Lidgey
Sociétés | Poste | Fin |
---|---|---|
NUFORMIX PLC | Directeur/Membre du Conseil | 31/01/2020 |
LTP Electronics Ltd. | Directeur/Membre du Conseil | - |
Nuformix Technologies Ltd.
![]() Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Levrett Plc
![]() Levrett Plc BiotechnologyHealth Technology Levrett Plc is a special purpose acquisition company. It is formed to acquire realizable and/or developed commercial technologies focused in the pharmaceutical and biotechnology sector. The company was founded on June 10, 2015 and is headquartered in London, the United Kingdom. | Président | - |
Formation de Francis Lidgey
The University of Newcastle | Doctorate Degree |
University of Surrey | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NUFORMIX PLC | Health Technology |
Entreprise privées | 4 |
---|---|
Nuformix Technologies Ltd.
![]() Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Levrett Plc
![]() Levrett Plc BiotechnologyHealth Technology Levrett Plc is a special purpose acquisition company. It is formed to acquire realizable and/or developed commercial technologies focused in the pharmaceutical and biotechnology sector. The company was founded on June 10, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Phibex Plc | |
LTP Electronics Ltd. |